Global Exporter & Bulk Supplier of Flulieva 50mg Injection

🌍 Introduction

Are you seeking a certified and reliable global exporter for Flulieva 50mg Injection? At Ernest Oncology (the premier oncology division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the international distribution of high-quality antineoplastic agents. We provide streamlined supply chain solutions for Fludarabine 50mg injections to hospitals, hematology centers, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Flulieva 50mg Injection

Flulieva 50mg Injection contains Fludarabine Phosphate, a potent fluorinated nucleotide analog. The 50mg high-strength vial is designed for intensive treatment protocols in hematological oncology.

• Composition: Fludarabine Phosphate 50mg (as a sterile lyophilized powder)

• Therapeutic Class: Antineoplastic / Antimetabolite (Purine Analog)

• Formulation Type: Single-dose vial for Intravenous (IV) infusion.

• Storage: Store at controlled room temperature ($20^\circ\text{C}$ to $25^\circ\text{C}$).

⚙️ 2. Mechanism of Action

Flulieva works by selectively inhibiting the DNA synthesis of rapidly dividing leukemic cells:

• Metabolic Activation: Fludarabine is rapidly dephosphorylated and then phosphorylated intracellularly into its active triphosphate form (2-fluoro-ara-ATP).

• Enzyme Inhibition: It inhibits key enzymes such as DNA polymerase alpha, ribonucleotide reductase, and DNA primase.

• Chain Termination: Once incorporated into the DNA, it acts as a chain terminator, effectively halting the replication and repair of cancer cell DNA.

• Apoptosis Induction: This process triggers programmed cell death (apoptosis) in malignant lymphocytes.

🏥 3. Therapeutic Indications

Flulieva 50mg Injection is clinically indicated for:

• Chronic Lymphocytic Leukemia (CLL): Primarily for patients who have not responded to or have progressed during standard alkylating agent therapy.

• Non-Hodgkin’s Lymphoma (NHL): Utilized in aggressive and low-grade lymphoma protocols.

• Acute Myeloid Leukemia (AML): Often used in combination "FLAG" regimens for refractory cases.

• Bone Marrow Transplant Conditioning: A critical component of reduced-intensity conditioning (RIC) regimens before stem cell transplantation.

⚠️ 4. Administration & Safety Guidelines

• Professional Use Only: Must be administered only via Intravenous (IV) Infusion by medical professionals experienced in cancer chemotherapy.

• High Potency: The 50mg vial allows for higher dosing efficiency; however, clinical adherence to strictly calculated body surface area (BSA) dosing is essential to avoid neurotoxicity.

• Hematologic Monitoring: Regular monitoring of blood counts is mandatory due to significant bone marrow suppression.

• Immune System Support: Due to profound T-cell depletion, patients are at high risk for opportunistic infections and often require prophylactic treatment

•